Residual neuromuscular blockade and postoperative pulmonary outcome: The missing piece of the puzzle

European Journal of Anaesthesiology

Volumn 31, Issue 8, 2014, Pages 401-403

  Fuchs Buder, Thomas ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; NEOSTIGMINE; ROCURONIUM; SUGAMMADEX; ANDROSTANE DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ACUTE INTERMITTENT PORPHYRIA; ANESTHESIA LEVEL; BISPECTRAL INDEX; DIABETES MELLITUS; HUMAN; LUNG FUNCTION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR MONITORING; NOTE; POSTOPERATIVE CARE; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PERIOD; FEMALE; MALE; PROCEDURES;

ANDROSTANOLS; DEXAMETHASONE; FEMALE; HUMANS; MALE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 84905447346     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000065     Document Type: Note

References (19)

1. Soltész S, Fraisl P, NoéKG, et al. Dexamethasone decreases the duration of rocuronium-induced neuromuscular block. A randomised controlled study. Eur J Anaesthesiol 2014; 31:417-422.
2. Buijs EJ, Scholten JGF, Ros JJW. Successful administration of sugammadex in a patient with acute porphyria. A case report. Eur J Anaesthesiol 2014; 31:439-441.
3. Christ B,Guerci P, Baumann C, et al. Influence of neuromuscular block and reversal on bispectral index and NeuroSense values. Eur J Anaesthesiol 2014; 31:437-439.
4. Dubois PE, De Bel M, Jamart J, et al. Performance of acceleromyography with a short and light TOF-tube compared with mechanomyography. A clinical comparison. Eur J Anaesthesiol 2014; 31:404-410.
5. Armendáriz-Buil I, Lobato-Solares F, Aguilera-Celorrio L, et al. Residual neuromuscular block in type II diabetes mellitus after rocuronium. A prospective observational study. Eur J Anaesthesiol 2014; 31:411-416.
6. Ledowski T, Falke L, Johnston F, et al. Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade. Sugammadex, neostigmine or no reversal. Eur J Anaesthesiol 2014; 31:423-429.
7. Nitahara K, Sugi Y, Shigematsu K, et al. Recovery of a train-of-four ratio to 0.7 and 0.9 is delayed in type II diabetes with vecuroniuminduced neuromuscular block. Eur J Anaesthesiol 2013; 30:80-84.
8. Berg H, Roed j, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomized, and blinded study of postoperative pulmonary complications after atracurium, vecuronium, and pancuronium. Acta Anaesthesiol Scand 1997; 41:1095-1103.
9. Murphy GS, Szokol JW, Marymont JH, et al. Residual neuromuscular blockade and critical respiratory events in the postanaesthesia care unit. Anesth Analg 2008; 107:130-137.
10. Sauer M, Stahn A, Soltész S, et al. The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial. Eur J Anaesthesiol 2011; 28:842-848.
11. Sundman E, Witt H, Olsson R, et al. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 2000; 92:977-984.
12. Herbstreit F, Peters J, Eikermann M. Impaired upper airway integrity by residual neuromuscular blockade: increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology 2009; 110:1253-1260.
13. Grosse-Sundrup M, Henneman PJ, Sandberg WS, et al. Intermediate acting nondepolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ 2012; 345:e6329.
14. Blobner M, Eriksson LI, Scholz J, et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised controlled trial. Eur J Anaesthesiol 2010; 27:874-881.
15. Esteves S, Martins M, Barros F, et al. Incidence of postoperative residual neuromuscular blockade in the postanaesthesia care unit: an observational multicenter study in Portugal. Eur J Anaesthesiol 2013; 30:243-249.
16. Kopman AF, Zank LM, Ng J, Neuman GG. Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: should quantitative assessment of neuromuscular function be mandatory? Anesth Analg 2004; 98:102-106.
17. Kirkegaard H, Heier T, Caldwell JE. Efficacy of tactile-guided reversal from cisatracurium neuromuscular block. Anesthesiology 2002; 96:45-50.
18. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112:1013-1022.
19. Fuchs-Buder T, Baumann C, De Guis J, et al. Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: a prospective, randomised controlled trial. Eur J Anaesthesiol 2013; 30:594-598.